| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w28031 |
| 来源ID | Working Paper 28031 |
| Economic Benefits of COVID-19 Screening Tests | |
| Andrew Atkeson; Michael C. Droste; Michael Mina; James H. Stock | |
| 发表日期 | 2020-11-02 |
| 出版年 | 2020 |
| 语种 | 英语 |
| 摘要 | We assess the economic value of screening testing programs as a policy response to the ongoing COVID-19 pandemic. We find that the fiscal, macroeconomic, and health benefits of rapid SARS-CoV-2 screening testing programs far exceed their costs, with the ratio of economic benefits to costs typically in the range of 4-15 (depending on program details), not counting the monetized value of lives saved. Unless the screening test is highly specific, however, the signal value of the screening test alone is low, leading to concerns about adherence. Confirmatory testing increases the net economic benefits of screening tests by reducing the number of healthy workers in quarantine and by increasing adherence to quarantine measures. The analysis is undertaken using a behavioral SIR model for the United States with 5 age groups, 66 economic sectors, screening and diagnostic testing, and partial adherence to instructions to quarantine or to isolate. |
| 主题 | Macroeconomics ; Fiscal Policy ; Health, Education, and Welfare ; Health ; COVID-19 |
| URL | https://www.nber.org/papers/w28031 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/585704 |
| 推荐引用方式 GB/T 7714 | Andrew Atkeson,Michael C. Droste,Michael Mina,et al. Economic Benefits of COVID-19 Screening Tests. 2020. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w28031.pdf（1920KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
